Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies

Introduction SETBP1 mutations have been established as a diagnostic marker in myeloid malignancies and are associated with inferior survival. Since there is limited data on their clinical impact and stability during disease progression, we sought to investigate the relationship between SETBP1 mutati...

Ausführliche Beschreibung